Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.04
+0.39 (6.90%)
At close: May 20, 2026, 4:00 PM EDT
6.16
+0.12 (1.99%)
After-hours: May 20, 2026, 4:41 PM EDT

Entrada Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.7425.42210.78129.01--
Revenue Growth (YoY)
-96.67%-87.94%63.38%---
Gross Profit
5.7425.42210.78129.01--
Selling, General & Admin
40.941.0538.4732.2930.6415.2
Research & Development
143.25142.27125.3199.8866.6135.93
Total Operating Expenses
184.15183.32163.77132.1897.2551.13
Operating Income
-178.41-157.947.01-3.16-97.25-51.13
Interest Income
13.2615.0719.4715.222.63-0.03
Total Non-Operating Income (Expense)
13.2615.0719.4715.222.63-0.03
Pretax Income
-165.16-142.8366.4912.06-94.62-51.16
Provision for Income Taxes
0.960.920.86-18.74--
Net Income
-166.12-143.7565.63-6.69-94.62-51.16
Net Income to Common
-166.12-143.7565.63-6.69-94.62-51.16
Shares Outstanding (Basic)
42413733316
Shares Outstanding (Diluted)
42413933316
Shares Change (YoY)
3.73%6.07%18.01%5.62%399.27%467.09%
EPS (Basic)
-3.99-3.471.76-0.20-3.02-8.16
EPS (Diluted)
-3.99-3.471.68-0.20-3.02-8.16
Shares Outstanding
38.8238.2837.5733.4431.3931.22
Free Cash Flow
-131.64-129.55-44.72134.19-96.67-55.44
Free Cash Flow Per Share
-3.17-3.13-1.154.06-3.09-8.85
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-3109.29%-621.13%22.30%-2.45%--
Profit Margin
-2895.05%-565.48%31.13%23.87%--
FCF Margin
-2294.20%-509.63%-21.21%104.01%--
EBITDA
-174.46-153.850.78-0.32-95.35-50.01
EBITDA Margin
-3040.36%-605.02%24.09%-0.25%--
EBIT
-178.41-157.947.01-3.16-97.25-51.13
EBIT Margin
-3109.29%-621.13%22.30%-2.45%--
Effective Tax Rate
-0.58%-0.65%1.29%-155.45%0.00%0.00%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q